
Somi IV Injection
Marketer
Desun Pharmaceuticals
Salt Composition
Esomeprazole (40mg)
Overview Somi IV Injection
Injex Somi is an intravenous medication that diminishes gastric acid secretion. It's indicated for treating stomach and intestinal disorders stemming from excess acidity, including acid reflux and other hyperacidity conditions. Injex Somi also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this medication is intravenously administered by a healthcare provider only when deemed clinically preferable to oral formulations. Dosage and treatment duration are individualized based on patient response and underlying health. Optimal therapeutic outcomes are enhanced by frequent, smaller meals and avoidance of caffeinated beverages, spicy, and fatty foods. Commonly reported adverse effects include injection site reactions, nausea, headache, dizziness, flatulence, diarrhea, abdominal pain, and fundic gland polyps. While typically mild, persistent or bothersome symptoms warrant medical attention. To mitigate potential bone loss (osteoporosis), discuss calcium and vitamin D supplementation with your physician. Injex Somi is contraindicated in individuals with severe hepatic impairment, those concurrently using HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to its potential to exacerbate gastric acid production and worsen symptoms.
Uses of Somi IV Injection
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Somi IV Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Somi IV Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Somi IV Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Somi IV Injection works:
Gastric acid production is diminished by the proton pump inhibitor Somi IV Injection, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Somi IV Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Somi IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Administration of Somi IV Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Somi IV Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Administering Somi IV Injection requires careful consideration in individuals with advanced kidney impairment. Dosage modification for Somi IV Injection might be necessary. Physician consultation is advised. Dosage alteration is unnecessary for patients exhibiting mild or moderate kidney dysfunction.
LiverCAUTION
Patients with severe hepatic impairment should receive Somi IV Injection with careful monitoring. Dosage modification may be necessary in such cases; physician consultation is advised. Dosage alteration is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Somi IV Injection :
Omit a dose of Somi IV Injection? Seek your physician's advice.
Facts to Know About Somi IV Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Behavioral Class | Gastric acid suppressants |
